1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Basal Insulin (Long-Acting Insulin) Consumption 2016-2026 2.1.2 Basal Insulin (Long-Acting Insulin) Consumption CAGR by Region 2.2 Basal Insulin (Long-Acting Insulin) Segment by Type 2.2.1 Lantus 2.2.2 Levemir 2.2.3 Tresiba 2.2.4 Toujeo 2.2.5 Basaglar 2.2.6 Biosimilar Glargines 2.3 Basal Insulin (Long-Acting Insulin) Sales by Type 2.3.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2016-2021) 2.3.2 Global Basal Insulin (Long-Acting Insulin) Revenue and Market Share by Type (2016-2021) 2.3.3 Global Basal Insulin (Long-Acting Insulin) Sale Price by Type (2016-2021) 2.4 Basal Insulin (Long-Acting Insulin) Segment by Application 2.4.1 Type 1 Diabetes 2.4.2 Type 2 Diabetes 2.5 Basal Insulin (Long-Acting Insulin) Sales by Application 2.5.1 Global Basal Insulin (Long-Acting Insulin) Sale Market Share by Application (2016-2021) 2.5.2 Global Basal Insulin (Long-Acting Insulin) Revenue and Market Share by Application (2016-2021) 2.5.3 Global Basal Insulin (Long-Acting Insulin) Sale Price by Application (2016-2021) 3 Global Basal Insulin (Long-Acting Insulin) by Company 3.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Company 3.1.1 Global Basal Insulin (Long-Acting Insulin) Sales by Company (2019-2021) 3.1.2 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Company (2019-2021) 3.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company 3.2.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Company (2019-2021) 3.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company (2019-2021) 3.3 Global Basal Insulin (Long-Acting Insulin) Sale Price by Company 3.4 Global Manufacturers Basal Insulin (Long-Acting Insulin) Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Basal Insulin (Long-Acting Insulin) Product Location Distribution 3.4.2 Players Basal Insulin (Long-Acting Insulin) Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 Basal Insulin (Long-Acting Insulin) by Region 4.1 Global Basal Insulin (Long-Acting Insulin) by Region 4.1.1 Global Basal Insulin (Long-Acting Insulin) Sales by Region 4.1.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Region 4.2 Americas Basal Insulin (Long-Acting Insulin) Sales Growth 4.3 APAC Basal Insulin (Long-Acting Insulin) Sales Growth 4.4 Europe Basal Insulin (Long-Acting Insulin) Sales Growth 4.5 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Growth 5 Americas 5.1 Americas Basal Insulin (Long-Acting Insulin) Sales by Country 5.1.1 Americas Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021) 5.1.2 Americas Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021) 5.2 Americas Basal Insulin (Long-Acting Insulin) Sales by Type 5.3 Americas Basal Insulin (Long-Acting Insulin) Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Basal Insulin (Long-Acting Insulin) Sales by Region 6.1.1 APAC Basal Insulin (Long-Acting Insulin) Sales by Region (2016-2021) 6.1.2 APAC Basal Insulin (Long-Acting Insulin) Revenue by Region (2016-2021) 6.2 APAC Basal Insulin (Long-Acting Insulin) Sales by Type 6.3 APAC Basal Insulin (Long-Acting Insulin) Sales by Application 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Basal Insulin (Long-Acting Insulin) by Country 7.1.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021) 7.1.2 Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021) 7.2 Europe Basal Insulin (Long-Acting Insulin) Sales by Type 7.3 Europe Basal Insulin (Long-Acting Insulin) Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Basal Insulin (Long-Acting Insulin) by Country 8.1.1 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021) 8.1.2 Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021) 8.2 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Type 8.3 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Country 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Marketing, Distributors and Customer 10.1 Sales Channel 10.1.1 Direct Channels 10.1.2 Indirect Channels 10.2 Basal Insulin (Long-Acting Insulin) Distributors 10.3 Basal Insulin (Long-Acting Insulin) Customer 11 Global Basal Insulin (Long-Acting Insulin) Market Forecast 11.1 Global Basal Insulin (Long-Acting Insulin) Forecast by Region 11.1.1 Global Basal Insulin (Long-Acting Insulin) Forecast by Regions (2021-2026) 11.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Regions (2021-2026) 11.2 Americas Forecast by Country 11.3 APAC Forecast by Region 11.4 Europe Forecast by Country 11.5 Middle East & Africa Forecast by Country 11.6 Global Basal Insulin (Long-Acting Insulin) Forecast by Type 11.7 Global Basal Insulin (Long-Acting Insulin) Forecast by Application 12 Key Players Analysis 12.1 Novo Nordisk 12.1.1 Novo Nordisk Company Information 12.1.2 Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Offered 12.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021) 12.1.4 Novo Nordisk Main Business Overview 12.1.5 Novo Nordisk Latest Developments 12.2 Sanofi Aventis 12.2.1 Sanofi Aventis Company Information 12.2.2 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Offered 12.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021) 12.2.4 Sanofi Aventis Main Business Overview 12.2.5 Sanofi Aventis Latest Developments 12.3 Eli Lilly 12.3.1 Eli Lilly Company Information 12.3.2 Eli Lilly Basal Insulin (Long-Acting Insulin) Product Offered 12.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021) 12.3.4 Eli Lilly Main Business Overview 12.3.5 Eli Lilly Latest Developments 12.4 Biocon 12.4.1 Biocon Company Information 12.4.2 Biocon Basal Insulin (Long-Acting Insulin) Product Offered 12.4.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021) 12.4.4 Biocon Main Business Overview 12.4.5 Biocon Latest Developments 12.5 Julphar 12.5.1 Julphar Company Information 12.5.2 Julphar Basal Insulin (Long-Acting Insulin) Product Offered 12.5.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021) 12.5.4 Julphar Main Business Overview 12.5.5 Julphar Latest Developments 12.6 Exir 12.6.1 Exir Company Information 12.6.2 Exir Basal Insulin (Long-Acting Insulin) Product Offered 12.6.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021) 12.6.4 Exir Main Business Overview 12.6.5 Exir Latest Developments 12.7 Sedico 12.7.1 Sedico Company Information 12.7.2 Sedico Basal Insulin (Long-Acting Insulin) Product Offered 12.7.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021) 12.7.4 Sedico Main Business Overview 12.7.5 Sedico Latest Developments 12.8 Wockhardt 12.8.1 Wockhardt Company Information 12.8.2 Wockhardt Basal Insulin (Long-Acting Insulin) Product Offered 12.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2019-2021) 12.8.4 Wockhardt Main Business Overview 12.8.5 Wockhardt Latest Developments 13 Research Findings and Conclusion

List of Tables Table 1. Basal Insulin (Long-Acting Insulin) Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Lantus Table 3. Major Players of Levemir Table 4. Major Players of Tresiba Table 5. Major Players of Toujeo Table 6. Major Players of Basaglar Table 7. Major Players of Biosimilar Glargines Table 8. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2016-2021) & (K Units) Table 9. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2016-2021) Table 10. Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2016-2021) & ($ million) Table 11. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2016-2021) Table 12. Global Basal Insulin (Long-Acting Insulin) Sale Price by Type (2016-2021) Table 13. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2016-2021) & (K Units) Table 14. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2016-2021) Table 15. Global Basal Insulin (Long-Acting Insulin) Value by Application (2016-2021) Table 16. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2016-2021) Table 17. Global Basal Insulin (Long-Acting Insulin) Sale Price by Application (2016-2021) Table 18. Global Basal Insulin (Long-Acting Insulin) Sales by Company (2019-2021) & (K Units) Table 19. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Company (2019-2021) Table 20. Global Basal Insulin (Long-Acting Insulin) Revenue by Company (2019-2021) ($ Millions) Table 21. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company (2019-2021) Table 22. Global Basal Insulin (Long-Acting Insulin) Sale Price by Company (2019-2021) Table 23. Key Manufacturers Basal Insulin (Long-Acting Insulin) Producing Area Distribution and Sales Area Table 24. Players Basal Insulin (Long-Acting Insulin) Products Offered Table 25. Basal Insulin (Long-Acting Insulin) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 26. New Products and Potential Entrants Table 27. Mergers & Acquisitions, Expansion Table 28. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2016-2021) (K Units) Table 29. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2016-2021) Table 30. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2016-2021) & ($ Millions) Table 31. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2016-2021) Table 32. Americas Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021) & (K Units) Table 33. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2016-2021) Table 34. Americas Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021) & ($ Millions) Table 35. Americas Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2016-2021) Table 36. Americas Basal Insulin (Long-Acting Insulin) Sales by Type (2016-2021) & (K Units) Table 37. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2016-2021) Table 38. Americas Basal Insulin (Long-Acting Insulin) Sales by Application (2016-2021) & (K Units) Table 39. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2016-2021) Table 40. APAC Basal Insulin (Long-Acting Insulin) Sales by Region (2016-2021) & (K Units) Table 41. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2016-2021) Table 42. APAC Basal Insulin (Long-Acting Insulin) Revenue by Region (2016-2021) & ($ Millions) Table 43. APAC Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2016-2021) Table 44. APAC Basal Insulin (Long-Acting Insulin) Sales by Type (2016-2021) & (K Units) Table 45. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2016-2021) Table 46. APAC Basal Insulin (Long-Acting Insulin) Sales by Application (2016-2021) & (K Units) Table 47. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2016-2021) Table 48. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021) & (K Units) Table 49. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2016-2021) Table 50. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021) & ($ Millions) Table 51. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2016-2021) Table 52. Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2016-2021) & (K Units) Table 53. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2016-2021) Table 54. Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2016-2021) & (K Units) Table 55. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2016-2021) Table 56. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2016-2021) & (K Units) Table 57. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2016-2021) Table 58. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2016-2021) & ($ Millions) Table 59. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2016-2021) Table 60. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Type (2016-2021) & (K Units) Table 61. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2016-2021) Table 62. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Application (2016-2021) & (K Units) Table 63. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2016-2021) Table 64. Key and Potential Regions of Basal Insulin (Long-Acting Insulin) Table 65. Key Application and Potential Industries of Basal Insulin (Long-Acting Insulin) Table 66. Key Challenges of Basal Insulin (Long-Acting Insulin) Table 67. Key Trends of Basal Insulin (Long-Acting Insulin) Table 68. Basal Insulin (Long-Acting Insulin) Distributors List Table 69. Basal Insulin (Long-Acting Insulin) Customer List Table 70. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Region (2021-2026) & (K Units) Table 71. Global Basal Insulin (Long-Acting Insulin) Consumption Market Forecast by Region Table 72. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Region (2021-2026) & ($ millions) Table 73. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Region (2021-2026) Table 74. Americas Basal Insulin (Long-Acting Insulin) Sales Forecast by Country (2021-2026) & (K Units) Table 75. Americas Basal Insulin (Long-Acting Insulin) Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. APAC Basal Insulin (Long-Acting Insulin) Sales Forecast by Region (2021-2026) & (K Units) Table 77. APAC Basal Insulin (Long-Acting Insulin) Revenue Forecast by Region (2021-2026) & ($ millions) Table 78. Europe Basal Insulin (Long-Acting Insulin) Sales Forecast by Country (2021-2026) & (K Units) Table 79. Europe Basal Insulin (Long-Acting Insulin) Revenue Forecast by Country (2021-2026) & ($ millions) Table 80. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Forecast by Country (2021-2026) & (K Units) Table 81. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue Forecast by Country (2021-2026) & ($ millions) Table 82. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Type (2021-2026) & (K Units) Table 83. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Forecast by Type (2021-2026) Table 84. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Type (2021-2026) & ($ Millions) Table 85. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Type (2021-2026) Table 86. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Application (2021-2026) & (K Units) Table 87. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Forecast by Application (2021-2026) Table 88. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Application (2021-2026) & ($ Millions) Table 89. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Application (2021-2026) Table 90. Novo Nordisk Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors Table 91. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Offered Table 92. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 93. Novo Nordisk Main Business Table 94. Novo Nordisk Latest Developments Table 95. Sanofi Aventis Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors Table 96. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Offered Table 97. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 98. Sanofi Aventis Main Business Table 99. Sanofi Aventis Latest Developments Table 100. Eli Lilly Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors Table 101. Eli Lilly Basal Insulin (Long-Acting Insulin) Product Offered Table 102. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 103. Eli Lilly Main Business Table 104. Eli Lilly Latest Developments Table 105. Biocon Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors Table 106. Biocon Basal Insulin (Long-Acting Insulin) Product Offered Table 107. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 108. Biocon Main Business Table 109. Biocon Latest Developments Table 110. Julphar Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors Table 111. Julphar Basal Insulin (Long-Acting Insulin) Product Offered Table 112. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 113. Julphar Main Business Table 114. Julphar Latest Developments Table 115. Exir Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors Table 116. Exir Basal Insulin (Long-Acting Insulin) Product Offered Table 117. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 118. Exir Main Business Table 119. Exir Latest Developments Table 120. Sedico Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors Table 121. Sedico Basal Insulin (Long-Acting Insulin) Product Offered Table 122. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 123. Sedico Main Business Table 124. Sedico Latest Developments Table 125. Wockhardt Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors Table 126. Wockhardt Basal Insulin (Long-Acting Insulin) Product Offered Table 127. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 128. Wockhardt Main Business Table 129. Wockhardt Latest Developments List of Figures Figure 1. Picture of Basal Insulin (Long-Acting Insulin) Figure 2. Basal Insulin (Long-Acting Insulin) Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Basal Insulin (Long-Acting Insulin) Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Basal Insulin (Long-Acting Insulin) Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Basal Insulin (Long-Acting Insulin) Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Lantus Figure 10. Product Picture of Levemir Figure 11. Product Picture of Tresiba Figure 12. Product Picture of Toujeo Figure 13. Product Picture of Basaglar Figure 14. Product Picture of Biosimilar Glargines Figure 15. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type in 2020 Figure 16. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2016-2021) Figure 17. Basal Insulin (Long-Acting Insulin) Consumed in Type 1 Diabetes Figure 18. Global Basal Insulin (Long-Acting Insulin) Market: Type 1 Diabetes (2016-2021) & (K Units) Figure 19. Basal Insulin (Long-Acting Insulin) Consumed in Type 2 Diabetes Figure 20. Global Basal Insulin (Long-Acting Insulin) Market: Type 2 Diabetes (2016-2021) & (K Units) Figure 21. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2016-2021) Figure 22. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application in 2020 Figure 23. Basal Insulin (Long-Acting Insulin) Revenue Market by Company in 2020 ($ Million) Figure 24. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company in 2020 Figure 25. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Regions (2016-2021) Figure 26. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region in 2020 Figure 27. Americas Basal Insulin (Long-Acting Insulin) Sales 2016-2021 (K Units) Figure 28. Americas Basal Insulin (Long-Acting Insulin) Revenue 2016-2021 ($ Millions) Figure 29. APAC Basal Insulin (Long-Acting Insulin) Sales 2016-2021 (K Units) Figure 30. APAC Basal Insulin (Long-Acting Insulin) Revenue 2016-2021 ($ Millions) Figure 31. Europe Basal Insulin (Long-Acting Insulin) Sales 2016-2021 (K Units) Figure 32. Europe Basal Insulin (Long-Acting Insulin) Revenue 2016-2021 ($ Millions) Figure 33. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales 2016-2021 (K Units) Figure 34. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue 2016-2021 ($ Millions) Figure 35. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2020 Figure 36. Americas Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2020 Figure 37. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Type in 2020 Figure 38. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Application in 2020 Figure 39. United States Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 40. Canada Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 41. Mexico Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 42. Brazil Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 43. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Region in 2020 Figure 44. APAC Basal Insulin (Long-Acting Insulin) Revenue Market Share by Regions in 2020 Figure 45. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Type in 2020 Figure 46. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Application in 2020 Figure 47. China Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 48. Japan Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 49. Korea Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 50. Southeast Asia Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 51. India Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 52. Australia Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 53. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2020 Figure 54. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2020 Figure 55. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Type in 2020 Figure 56. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Application in 2020 Figure 57. Germany Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 58. France Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 59. UK Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 60. Italy Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 61. Russia Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 62. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2020 Figure 63. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2020 Figure 64. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Type in 2020 Figure 65. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Application in 2020 Figure 66. Egypt Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 67. South Africa Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 68. Israel Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 69. Turkey Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 70. GCC Country Basal Insulin (Long-Acting Insulin) Revenue Growth 2016-2021 ($ Millions) Figure 71. Channels of Distribution Figure 72. Distributors Profiles